Revenue (Tables)

3 Months Ended

Mar. 31, 2022

Disaggregation Of Revenue [Abstract]

Summary of information about disaggregated revenue by product mix

The following table provides information about disaggregated revenue by product mix and service (in thousands):

	Three Months Ended March 31,
	2022		2021
Product revenue:
ANNOVERA	$	8,510	$	8,750
IMVEXXY		6,969		7,012
BIJUVA		2,560		2,445
Prescription vitamin		875		1,425
Product revenue, net		18,914		19,632
License and service		419		234
Total revenue, net	$	19,333	$	19,866